相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update
Ryosuke Tateishi et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial
Masahiro Hatooka et al.
BMC CANCER (2018)
The Plausibility of Obesity Paradox in Cancer
Yikyung Park et al.
CANCER RESEARCH (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
No Muscle Depletion with High Visceral Fat as a Novel Beneficial Biomarker of Sorafenib for Hepatocellular Carcinoma
Issei Saeki et al.
LIVER CANCER (2018)
Lenvatinib May Drastically Change the Treatment Landscape of Hepatocellular Carcinoma
Masatoshi Kudo
LIVER CANCER (2018)
Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib
Atsushi Hiraoka et al.
HEPATOLOGY RESEARCH (2017)
Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy
Hiroki Nishikawa et al.
ONCOLOGY LETTERS (2017)
Beneficial Effect of Maintaining Hepatic Reserve during Chemotherapy on the Outcomes of Patients with Hepatocellular Carcinoma
Takeshi Terashima et al.
LIVER CANCER (2017)
Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis
Atsushi Hiraoka et al.
DIGESTIVE DISEASES (2017)
Response to chemotherapy improves hepatic reserve for patients with hepatocellular carcinoma and Child-Pugh B cirrhosis
Takeshi Terashima et al.
CANCER SCIENCE (2016)
Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria
Hiroki Nishikawa et al.
HEPATOLOGY RESEARCH (2016)
Sarcopenia and cachexia in the era of obesity: clinical and nutritional impact
C. M. Prado et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2016)
Body Composition Features Predict Overall Survival in Patients With Hepatocellular Carcinoma
Amit G. Singal et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
A Comparison of the Surgical Outcomes Among Patients With HBV-positive, HCV-positive, and Non-B Non-C Hepatocellular Carcinoma A Nationwide Study of 11,950 Patients
Tohru Utsunomiya et al.
ANNALS OF SURGERY (2015)
Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors
Jean-Charles Nault et al.
DIGESTIVE AND LIVER DISEASE (2015)
General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan
Masatoshi Kudo et al.
DIGESTIVE DISEASES (2015)
Skeletal Muscle Depletion Predicts the Prognosis of Patients with Hepatocellular Carcinoma Treated with Sorafenib
Kenji Imai et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma
Naoto Fujiwara et al.
JOURNAL OF HEPATOLOGY (2015)
OBESITY AND DIABETES: THE INCREASED RISK OF CANCER AND CANCER-RELATED MORTALITY
Emily Jane Gallagher et al.
PHYSIOLOGICAL REVIEWS (2015)
Adipokines at the crossroad between obesity and cardiovascular disease
Filippo Molica et al.
THROMBOSIS AND HAEMOSTASIS (2015)
Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma
Tadaaki Arizumi et al.
LIVER CANCER (2015)
A New Therapeutic Assessment Score for Advanced Hepatocellular Carcinoma Patients Receiving Hepatic Arterial Infusion Chemotherapy
Issei Saeki et al.
PLOS ONE (2015)
Effect of Body Composition on Outcomes after Hepatic Resection for Hepatocellular Carcinoma
Shinji Itoh et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization
Sadahisa Ogasawara et al.
ONCOLOGY (2014)
JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan
Masatoshi Kudo et al.
LIVER CANCER (2014)
Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan
K. Nouso et al.
BRITISH JOURNAL OF CANCER (2013)
Sarcopenia as a Prognostic Index of Nutritional Status in Concurrent Cirrhosis and Hepatocellular Carcinoma
Judith Meza-Junco et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)
Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy
Daisuke Miyaki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study)
Aki Hiuge-Shimizu et al.
ANNALS OF MEDICINE (2012)
Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C. Verslype et al.
ANNALS OF ONCOLOGY (2012)
Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma
Julien Edeline et al.
CANCER (2012)
Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy
Takashi Niizeki et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma according to Child-Pugh classification
Daisuke Miyaki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
Masatoshi Kudo et al.
DIGESTIVE DISEASES (2011)
Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)
Shigeki Arii et al.
HEPATOLOGY RESEARCH (2010)
Effect of a late evening snack using branched-chain amino acid-enriched nutrients in patients undergoing hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
Yohei Harima et al.
HEPATOLOGY RESEARCH (2010)
Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion
S Obi et al.
CANCER (2006)
Arterial infusion chemotherapy using cisplatin, 5-fluorouracil, and isovorin for patients with advanced hepatocellular carcinoma, pilot study: Is a high dose of the biochemical modulator effective?
T Yamasaki et al.
HEPATOLOGY RESEARCH (2003)
分享论文
